Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 5, 2013, Pages 527-536

  Torlot, F J ^a   McPhail, M J W ^a   Taylor Robinson, S D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; CRITICAL FLICKER FUSION; DATA EXTRACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ODDS RATIO; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EVENT RELATED POTENTIAL; HEPATIC ENCEPHALOPATHY; HUMAN; MINIMAL HEPATIC ENCEPHALOPATHY; PRIORITY JOURNAL; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; WECHSLER INTELLIGENCE SCALE;

FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84873413165     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12199     Document Type: Article

References (52)

1. Butterworth RF,. Editorial: rifaximin and minimal hepatic encephalopathy. Am J Gastroenterol 2011; 106: 317-8.
2. Poordad FF,. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25: 3-9.
3. Amodio P, Montagnese S, Gatta A, Morgan MY,. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-67.
4. Kircheis G, Knoche A, Hilger N, et al,. Hepatic Encephalopathy and Fitness to Drive. Gastroenterology 2009; 137: 1706-15.
5. Wein C, Koch H, Popp B, Oehler G, Schauder P,. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-45.
6. Cõrdoba J, Lucke R,. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004; 39: 599-601.
7. Bajaj JS, Saeian K, Schubert CM, et al,. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009; 50: 1175-83.
8. Schomerus H, Hamster W,. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41.
9. Groeneweg M, Quero JC, De Bruijn I, et al,. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
10. Hartmann IJC, Groeneweg M, Quero JC, et al,. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-34.
11. Romero-Gõmez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J,. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
12. Montagnese S, Biancardi A, Schiff S, et al,. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 2011; 53: 558-66.
13. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK,. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011; 106: 307-16.
14. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R,. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
15. Bajaj JS, Saeian K, Christensen KM, et al,. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1707-15.
16. Ndraha S, Hasan I, Simadibrata M,. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Med Indones 2011; 43: 18-22.
17. Shukla S, Shukla A, Mehboob S, Guha S,. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33: 662-71.
18. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K,. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007; 45: 833-4.
19. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
20. Amodio P, Campagna F, Olianas S, et al,. Detection of minimal hepatic encephalopathy: normalization and optimization of the psychometric hepatic encephalopathy score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49: 346-53.
21. Schomerus H, Hamster W,. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361-77.
22. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H,. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
23. Romero Gomez M, Cordoba J, Jover R, et al,. Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy. Med Clin 2006; 127: 246-9.
24. Bajaj JS, Saeian K, Verber MD, et al,. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007; 102: 754-60.
25. Bajaj JS, Hafeezullah M, Franco J, et al,. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135: 1591-600.
26. Mardini H, Saxby BK, Record CO,. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008; 135: 1582-90.
27. Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N,. Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroenterol 1981; 16: 441-7.
28. Elsass P, Christensen SE, Mortensen EL, Vilstrup H,. Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 1985; 5: 29-34.
29. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D,. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.
30. Baatz H, Raak P, de Ortueta D, Mirshahi A, Scharioth G,. Practical significance of critical fusion frequency (CFF). Chronological resolution of the visual system in differential diagnosis. Ophthalmologe 2010; 107: 715-9.
31. Bajaj JS,. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 2010; 31: 537-47.
32. Bossuyt PM, Reitsma JB, Bruns DE, et al,. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49: 7-18.
33. Bossuyt PM, Reitsma JB, Bruns DE, et al,. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract 2004; 21: 4-10.
34. Leemis LM, Trivedi KS,. A comparison of approximate interval estimators for the Bernoulli parameter. The American Statistician 1996; 50: 63-8.
35. Moses LE, Shapiro D, Littenberg B,. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12: 1293-316.
36. Higgins JPT, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
37. Deeks JJ, Macaskill P, Irwig L,. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882-93.
38. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A,. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
39. Romero-Gomez M, Cordoba J, Jover R, et al,. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-85.
40. Montoliu C, Piedrafita B, Serra MA, et al,. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med 2007; 85: 237-45.
41. Sharma P, Sharma BC, Puri V, Sarin SK,. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008; 103: 1406-12.
42. Montoliu C, Piedrafita B, Serra MA, et al,. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2009; 43: 272-9.
43. Dhiman RK, Kurmi R, Thumburu KK, et al,. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010; 55: 2381-90.
44. Goel A, Yadav S, Saraswat V, et al,. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction. Liver Int 2010; 30: 1143-51.
45. Sharma P, Sharma BC, Sarin SK,. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int 2010; 9: 27-32.
46. Maldonado-Garza HJ, Vazquez-Elizondo G, Gaytan-Torres JO, Flores-Rendon AR, Cardenas-Sandoval MG, Bosques-Padilla FJ,. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol 2011; 10 (Suppl. 2): S40-4.
47. Montagnese S, Schiff S, De Rui M, Crossey MM, Amodio P, Taylor-Robinson SD,. Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat 2012; 19: 307-15.
48. Onal IK, Akdogan M, Oztas E, Balci M, Kurt M, Kacar S, et al,. Does interleukin-18 play a role in the pathogenesis of hepatic encephalopathy? Hepatogastroenterology 2011; 58: 497-502.
49. Shawcross DL, Wright G, Olde Damink SW, Jalan R,. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-38.
50. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
51. Sharma P, Sharma BC, Puri V, Sarin SK,. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47: 67-73.
52. Sharma P, Sharma BC,. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol 2010; 16: 181-7.